Deutscher Forschungsverbund Neuropathischer Schmerz (DFNS)

454 Life Sciences obtains license from Pyrosequencing AB to next generation sequencing technology for whole genome Applications

Go to page

New hope in the battle against glioblastoma

Go to page

Successful Stem Cell Therapy for Treatment of Eye Disease

Go to page

PUREFY GmbH - Mainz, Germany

Go to page

DiscoveRx Corporation - Fremont, USA

Go to page

CEROBEAR GmbH - Herzogenrath, Germany

Go to page

Strand and Pharmidex to collaborate to produce a new in silico technology for CNS drug discovery

Go to page

Demand for Therapies to Treat Drug Resistant HIV Strains is Increasing, Finds Frost & Sullivan

Go to page

Robert_Ettinger

Go to page

Natural_Killer_T_cell

Go to page